Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

von McCormack, Steven E, Warlick, Erica D
Veröffentlicht 2010

Successful Remission Rates and Survival after Lymphodepleting Chemotherapy for Relapsed Hematologic Malignancies Postallogeneic Hematopoietic Cell Transplantation

von Warlick, Erica D., DeFor, Todd, Blazar, Bruce R., Burns, Linda, Verneris, Michael R., Ustun, Celalettin, Weisdorf, Daniel J., Miller, Jeffrey S.
Veröffentlicht 2011

Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling

von Oltvai, Zoltán N., Harley, Susan E., Koes, David, Michel, Stephen, Warlick, Erica D., Nelson, Andrew C., Yohe, Sophia, Mroz, Pawel
Veröffentlicht in Cold Spring Harb Mol Case Stud (2021)

Differences in Community and Academic Practice Patterns for Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients

von Pease, Daniel F., Ross, Julie A., Poynter, Jenny N., Nguyen, Phuong L., Hirsch, Betsy, Cioc, Adina, Roesler, Michelle A., Warlick, Erica D.
Veröffentlicht in Cancer Epidemiol (2015)

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

von Bejanyan, Nelli, Brunstein, Claudio G., Cao, Qing, Lazaryan, Aleksandr, Ustun, Celalettin, Warlick, Erica D., Arora, Mukta, Wagner, John E., Weisdorf, Daniel J.
Veröffentlicht in Blood Adv (2019)

Factors Predicting Early Mortality After New Diagnosis of Myelodysplastic Syndrome (MDS): A Population Based Study

von Jacobsen, Annie M., Poynter, Jenny N., Richardson, Michaela R., Nguyen, Phuong L., Hirsch, Betsy, Cioc, Adina, Roesler, Michelle A., Warlick, Erica D.
Veröffentlicht in Eur J Haematol (2019)

Reduced Intensity Hematopoietic-cell Transplantation in Older Patients with AML/MDS: Umbilical Cord Blood is a Feasible Option for Patients without HLA-matched Sibling Donors

von Majhail, Navneet S, Brunstein, Claudio G, Shanley, Ryan, Sandhu, Karamjeet, McClune, Brian, Oran, Betul, Warlick, Erica D, Wagner, John E, Weisdorf, Daniel J
Veröffentlicht 2011

Factors Associated with Hematopoietic Cell Transplantation (HCT) Among Patients in a Population Based Study of Myelodysplastic Syndrome (MDS) in Minnesota

von Smith, Angela R., Warlick, Erica D., Roesler, Michelle A., Poynter, Jenny N., Richardson, Michaela, Nguyen, Phuong, Cioc, Adina, Hirsch, Betsy, Ross, Julie A.
Veröffentlicht in Ann Hematol (2015)

Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome

von Ustun, Celalettin, Trottier, Bryan J., Sachs, Zohar, DeFor, Todd E., Shune, Leyla, Courville, Elizabeth, Holtan, Shernan G., Dolan, Michelle, Weisdorf, Daniel J., Warlick, Erica D.
Veröffentlicht in Biol Blood Marrow Transplant (2015)

Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect

von Rashidi, Armin, Ebadi, Maryam, Said, Bassil, Cao, Qing, Shanley, Ryan, Curtsinger, Julie, Bejanyan, Nelli, Warlick, Erica D., Green, Jaime S., Brunstein, Claudio G., Miller, Jeffrey S., Weisdorf, Daniel J.
Veröffentlicht in Am J Hematol (2018)

Allogeneic hematopoietic cell transplant outcomes in acute myeloid leukemia: Similar outcomes regardless of donor type

von Warlick, Erica D., de Latour, Regis Peffault, Shanley, Ryan, Robin, Marie, Bejanyan, Nelli, Xhaard, Alienor, Brunstein, Claudio, de Fontbrune, Flore Sicre, Ustun, Celalettin, Weisdorf, Daniel J, Socie, Gerard
Veröffentlicht in Biol Blood Marrow Transplant (2014)

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

von Eckfeldt, Craig E., Randall, Nicole, Shanley, Ryan M., Yohe, Sophia, Bejanyan, Nelli, Dolan, Michelle, Warlick, Erica D., Verneris, Michael R., Brunstein, Claudio G., Wagner, John E., Weisdorf, Daniel J., Ustun, Celalettin
Veröffentlicht in Haematologica (2016)

Phase 1 study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies

von Bachanova, Veronika, Frankel, Arthur E., Cao, Qing, Lewis, Dixie, Grzywacz, Bartosz, Verneris, Michael R., Ustun, Celalettin, Lazaryan, Aleksandr, McClune, Brian, Warlick, Erica D., Kantarjian, Hagop, Weisdorf, Daniel J., Miller, Jeffrey S., Vallera, Daniel A.
Veröffentlicht in Clin Cancer Res (2015)

Personalized Fludarabine Dosing To Reduce Non-Relapse Mortality In Hematopoietic Stem Cell Transplant Recipients Receiving Reduced Intensity Conditioning

von Sanghavi, Kinjal, Wiseman, Anthony, Kirstein, Mark N., Cao, Qing, Brundage, Richard, Jensen, Kyle, Rogosheske, John, Kurtzweil, Andy, Long-Boyle, Janel, Wagner, John, Warlick, Erica D., Brunstein, Claudio G, Weisdorf, Daniel J., Jacobson, Pamala A.
Veröffentlicht in Transl Res (2016)

Myeloablative Allogeneic Bone Marrow Transplant Using T Cell Depleted Allografts Followed by Post-Transplant GM-CSF in High Risk Myelodysplastic Syndromes

von Warlick, Erica D., O'Donnell, Paul V., Borowitz, Michael, Grupka, Nichon, Decloe, Lauren, Garrett-Mayer, Elizabeth, Borrello, Ivan, Brodsky, Robert, Fuchs, Ephraim, Huff, Carol Ann, Luznik, Leo, Matsui, William, Ambinder, Richard, Jones, Richard J., Smith, B. Douglas
Veröffentlicht 2008

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

von MacMillan, Margaret L., Hippen, Keli L., McKenna, David H., Kadidlo, Diane, Sumstad, Darin, DeFor, Todd E., Brunstein, Claudio G., Holtan, Shernan G., Miller, Jeffrey S., Warlick, Erica D., Weisdorf, Daniel J., Wagner, John E., Blazar, Bruce R.
Veröffentlicht in Blood Adv (2021)

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

von Keklik, Fatma, Alrawi, Ezzideen Barjes, Cao, Qing, Bejanyan, Nelli, Rashidi, Armin, Lazaryan, Aleksandr, Arndt, Patrick, Dincer, Erhan H., Bachanova, Veronika, Warlick, Erica D., MacMillan, Margaret L., Arora, Mukta, Miller, Jeffrey, Brunstein, Claudio G, Weisdorf, Daniel J., Ustun, Celalettin
Veröffentlicht in Haematologica (2018)

Hematopoietic Cell Transplant–Related Toxicities and Mortality in Frail Recipients

von Pamukcuoglu, Merve, Bhatia, Smita, Weisdorf, Daniel J., DeFor, Todd E., Ustun, Celalettin, Nayar, Manju, Holtan, Shernan G., Jurdi, Najla-El, Thyagarajan, Bharat, Brunstein, Claudio G., Bachanova, Veronika, Warlick, Erica D., Severseike, Ben, Te, Hok Sreng, Lund, Troy, Arora, Mukta
Veröffentlicht in Biol Blood Marrow Transplant (2019)

Matching at HLA-C improved the outcomes after double umbilical cord blood transplantation for recipients of 2–4/6 HLA-matched grafts

von Brunstein, Claudio G., Cutler, Corey S., DeFor, Todd E., Kim, Haesook, Bejanyan, Nelli, Garfall, Alfred, Verneris, Michael R., Chen, Yi-Bin, Warlick, Erica D., Spitzer, Thomas, Miller, Jeffrey S., Antin, Joseph H., Weisdorf, Daniel J., Soiffer, Robert, Wagner, John E., Ballen, Karen K.
Veröffentlicht in Biol Blood Marrow Transplant (2016)

Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF

von Smith, B. Douglas, Jones, Richard J., Cho, Eunpi, Kowalski, Jeanne, Karp, Judith E., Gore, Steven D., Vala, Milada, Meade, Brooke, Baker, Sharyn D., Zhao, Ming, Piantadosi, Steven, Zhang, Zhe, Blumenthal, Gideon, Warlick, Erica D., Brodsky, Robert A., Murgo, Anthony, Rudek, Michelle A., Matsui, William H.
Veröffentlicht 2010